Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» August 2011
August 2011
Vical: Making Progress In The Area Of HSV-2 Vaccines
Vical: Making Progress In The Area Of HSV-2 Vaccines
Seeking Alpha
Vical
Allovectin
herpes simplex 2
herpes simplex vaccine
Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines
Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines
Forbes
Pfizer
personalized medicine
Xalkori
lung cancer
crizotinib
4 Oversold Biotech Stocks Being Snapped Up By Insiders
4 Oversold Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Complete Genomics
MannKind
Corcept Therapeutics
Medivation
Does Affymetrix Hit Buffett's Target?
Does Affymetrix Hit Buffett's Target?
Motley Fool
Affymetrix
Biotech Sector Sees An Uptick As Investor Interest Returns
Biotech Sector Sees An Uptick As Investor Interest Returns
Forbes
Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
Yahoo/GlobeNewswire
StemCells
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Yahoo/MarketWire
Pluristem
Fibrocell Science
Cipla eyes alliances to grow in emerging markets
Cipla eyes alliances to grow in emerging markets
Fierce Pharma
emerging markets
Cipla
Warner Chilcott Stock Hits New 52-Week Low (WCRX)
Warner Chilcott Stock Hits New 52-Week Low (WCRX)
TheStreet.com
Warner Chilcott
The Long Term Bullish Case for Pharma
The Long Term Bullish Case for Pharma
Forbes
pharma industry
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »